Monoclonal Antibodies have been the latest addition to our Therapeutic Armamentum to deal with some complex disease conditions. The M-Ab COCKTAIL ( for early COVID infections ) that was a theme in my recent blog is the latest entrant. Many more will be available, after their successful production in Bio-Labs.
M-Abs are cool , revolutionary solutions to deal with devastating conditions.
Prior to the launch of the Antibody cocktail, many M-Abs have hit the Scientific Arena and helped deal with the following medical conditions 
Breast Cancer Multiple Sclerosis Inflammatory Bowel disease. Psoriasis Rheumatoid Arthritis AUTO-IMMUNE Hemolytic Anemias. Some Leukemias Non – Hodgkin Lymphomas Macular Degeneration in eyes, caused by increasing vascularity ( age related )
Medical Science has realized that many difficult – to – treat medical conditions can now be solved by the use of specific M-Abs. These conditions are characterised by cells, which have a harmful protein ( target antigen) on the surface of the pathological cells, which cannot be destroyed by our Innate Immunity. However, M-Abs can do this job by virtue of being LAB produced specific Artificial Antibodies , which are customized for this task.
Monoclonal Antibodies are targeted against a SINGLE TARGET ANTIGEN ( target protein ) and therefore, each M-Ab can possibly cure a single disorder, where this Target Antigen is the incriminating character, responsible for the dreaded disease.
MONOCLONAL means a SINGLE CLONE of identical antibodies, without any other class mixed up.
M-Abs also have DIAGNOSTIC APPLICATIONS besides their role in Therapeutics. These are their Diagnostic Uses :
PREGNANCY TEST is based on this principle , where the M-Antibodies bind to HCG hormone in the urine of pregnant women, inducing a color change.
M-Abs can bind to specific Target Antigens on Cancer cells, helping the location of Cancerous growth , thus of Diagnostic Value.
They can also be bound with Anti-cancer medications and when injected, will locate and bind to such cancer cells, allowing them to be killed by our INNATE Immune System. This is a novel therapeutic approach in Oncology.
After realizing all the POSITIVE ASPECTS of M-ABS, we ought to know about their NEGATIVES as under
These BIOLOGICAL products are very costly , although it is possible to grow them in infinite quantities . Their production is very time-consuming They have their side effects. Research is ongoing to solve this issue.
More info about Monoclonal Antibodies in the next two parts of this topic.
Share my BLOGS in your regional groups with all IAP colleagues. 
Deserving Candidate for IAP PRESIDENT ELECT 2022 in the coming IAP Elections